Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Platypus Technologies closes third round

Platypus Technologies closes third round

Posted on November 03, 2005

Platypus Technologies recently closed its third round of investment, raising $1.2 million from private investors. Platypus was qualified under the Wisconsin Act 255 which grants tax credits to individuals who invest in Wisconsin start up companies.

Platypus is developing an innovative platform technology using liquid crystals with applications in diagnostics, drug discovery and environmental monitoring.

The company is located in the New Venture Center on the Fitchburg Technology Campus and has 19 employees.

Platypus' regular legal counsel, Neider & Boucher, S.C., provided legal advice and support in connection with this fundraising. Neider & Boucher is located in the UW Research Park and works closely with many technology-based companies. According to Joe Boucher, this successful fundraising by Platypus "shows that angel funding is alive and well in Madison for the right projects in the right technology niche."

####
Contact:
Rajsree Minnie Gupta, PhD, MBA
Director of Marketing
Platypus Technologies, LLC
5520 Nobel Dr., Ste. 100
Madison, WI 53711
Tel: (608) 237-1270, ext. 303
Fax: (608) 237-1271
rgupta@platypustech.com

Copyright © Platypus Technologies

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Investments/IPO's/Splits

Daikin Industries becomes OCSiAl shareholder July 27th, 2021

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021

180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project